Cart 0

QY Research

China Remicade Biosimilar Market Research Report 2017

$3,200.00

Report Published By: QY Research
Publication Date : Feb-17
No. Of Pages: 123

Notes:
Sales, means the sales volume of Remicade Biosimilar
Revenue, means the sales value of Remicade Biosimilar

This report studies Remicade Biosimilar in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Teva Pharmaceutical Industries
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
100mg/10ml
500mg/50ml
Split by Application, this report focuses on consumption, market share and growth rate of Remicade Biosimilar in each application, can be divided into
Blood Disorders
Oncology Diseases

Table of Contents

China Remicade Biosimilar Market Research Report 2017
1 Remicade Biosimilar Market Overview
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 China Production Market Share of Remicade Biosimilar Type in 2015
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Applications of Remicade Biosimilar
1.3.1 Remicade Biosimilar Consumption Market Share by Application in 2015
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 China Market Size (Value) of Remicade Biosimilar (2012-2022)
1.5 China Remicade Biosimilar Status and Outlook
1.6 Government Policies

2 China Remicade Biosimilar Market Competition by Manufacturers
2.1 China Remicade Biosimilar Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Remicade Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Remicade Biosimilar Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Remicade Biosimilar Manufacturing Base Distribution, Sales Area, Product Type
2.5 Remicade Biosimilar Market Competitive Situation and Trends
2.5.1 Remicade Biosimilar Market Concentration Rate
2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 5 Manufacturers

3 China Remicade Biosimilar Manufacturers Profiles/Analysis
3.1 Teva Pharmaceutical Industries
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Remicade Biosimilar Product Type, Application and Specification
3.1.2.1 100mg/10ml
3.1.2.2 500mg/50ml
3.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Synthon Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Remicade Biosimilar Product Type, Application and Specification
3.2.2.1 100mg/10ml
3.2.2.2 500mg/50ml
3.2.3 Synthon Pharmaceuticals 123 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 LG Life Sciences
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Remicade Biosimilar Product Type, Application and Specification
3.3.2.1 100mg/10ml
3.3.2.2 500mg/50ml
3.3.3 LG Life Sciences 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Novartis (Sandoz)
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Remicade Biosimilar Product Type, Application and Specification
3.4.2.1 100mg/10ml
3.4.2.2 500mg/50ml
3.4.3 Novartis (Sandoz) Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Celltrion
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Remicade Biosimilar Product Type, Application and Specification
3.5.2.1 100mg/10ml
3.5.2.2 500mg/50ml
3.5.3 Celltrion Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Biocon
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Remicade Biosimilar Product Type, Application and Specification
3.6.2.1 100mg/10ml
3.6.2.2 500mg/50ml
3.6.3 Biocon Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Hospira
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Remicade Biosimilar Product Type, Application and Specification
3.7.2.1 100mg/10ml
3.7.2.2 500mg/50ml
3.7.3 Hospira Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Merck Serono (Merck Group)
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Remicade Biosimilar Product Type, Application and Specification
3.8.2.1 100mg/10ml
3.8.2.2 500mg/50ml
3.8.3 Merck Serono (Merck Group) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Biogen idec Inc.
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Remicade Biosimilar Product Type, Application and Specification
3.9.2.1 100mg/10ml
3.9.2.2 500mg/50ml
3.9.3 Biogen idec Inc. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Genentech (Roche Group)
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Remicade Biosimilar Product Type, Application and Specification
3.10.2.1 100mg/10ml
3.10.2.2 500mg/50ml
3.10.3 Genentech (Roche Group) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview

4 China Remicade Biosimilar Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Remicade Biosimilar Capacity, Production and Growth (2012-2017)
4.2 China Remicade Biosimilar Revenue and Growth (2012-2017)
4.3 China Remicade Biosimilar Production, Consumption, Export and Import (2012-2017)

5 China Remicade Biosimilar Production, Revenue (Value), Price Trend by Type
5.1 China Remicade Biosimilar Production and Market Share by Type (2012-2017)
5.2 China Remicade Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 China Remicade Biosimilar Price by Type (2012-2017)
5.4 China Remicade Biosimilar Production Growth by Type (2012-2017)

6 China Remicade Biosimilar Market Analysis by Application
6.1 China Remicade Biosimilar Consumption and Market Share by Application (2012-2017)
6.2 China Remicade Biosimilar Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaRemicade Biosimilar Market Analysis by Regions (Provinces)
7.1 China Remicade Biosimilar Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Remicade Biosimilar Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Remicade Biosimilar Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Remicade Biosimilar Sales Price by Regions (Provinces)(2012-2017)
7.2 China Remicade Biosimilar Consumption by Regions (Provinces)(2012-2017)
7.3 China Remicade Biosimilar Production, Consumption, Export and Import (2012-2017)

8 Remicade Biosimilar Manufacturing Cost Analysis
8.1 Remicade Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Remicade Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Remicade Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Remicade Biosimilar Market Forecast (2017-2022)
12.1 China Remicade Biosimilar Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Remicade Biosimilar Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Remicade Biosimilar Production Forecast by Type (2017-2022)
12.4 China Remicade Biosimilar Consumption Forecast by Application (2017-2022)
12.5 China Remicade Biosimilar Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Remicade Biosimilar Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Remicade Biosimilar Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Remicade Biosimilar Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Remicade Biosimilar Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


* indicates required information

* indicates required information


Share this Product


More from this collection